Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Preemptive Pregabalin in Children and Adolescents Undergoing Posterior Instrumented Spinal Fusion: A Double-Blinded, Placebo-Controlled, Randomized Clinical Trial.

Helenius LL, Oksanen H, Lastikka M, Pajulo O, Löyttyniemi E, Manner T, Helenius IJ.

J Bone Joint Surg Am. 2020 Feb 5;102(3):205-212. doi: 10.2106/JBJS.19.00650.

PMID:
31770296
2.

Back Pain and Quality of Life After Surgical Treatment for Adolescent Idiopathic Scoliosis at 5-Year Follow-up: Comparison with Healthy Controls and Patients with Untreated Idiopathic Scoliosis.

Helenius L, Diarbakerli E, Grauers A, Lastikka M, Oksanen H, Pajulo O, Löyttyniemi E, Manner T, Gerdhem P, Helenius I.

J Bone Joint Surg Am. 2019 Aug 21;101(16):1460-1466. doi: 10.2106/JBJS.18.01370.

PMID:
31436653
3.

Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients.

Uusalo P, Guillaume S, Siren S, Manner T, Vilo S, Scheinin M, Saari TI.

Anesth Analg. 2019 Jun 12. doi: 10.1213/ANE.0000000000004264. [Epub ahead of print]

PMID:
31206433
4.

Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study.

Uusalo P, Lehtinen M, Löyttyniemi E, Manner T, Scheinin M, Saari TI.

BMC Anesthesiol. 2019 Feb 13;19(1):22. doi: 10.1186/s12871-019-0690-1.

5.
6.

In Memoriam Professor Riku Aantaa: 1959-2016.

Suominen P, Lönnqvist PA, Manner T.

Paediatr Anaesth. 2017 Apr;27(4):444-445. doi: 10.1111/pan.13123. No abstract available.

PMID:
28300350
7.

Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects.

Yoo H, Iirola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, Olkkola KT, Jusko WJ.

Eur J Clin Pharmacol. 2015 Oct;71(10):1197-207. doi: 10.1007/s00228-015-1913-0. Epub 2015 Aug 2.

PMID:
26233335
8.

Bioavailability of dexmedetomidine after intranasal administration.

Iirola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, Olkkola KT.

Eur J Clin Pharmacol. 2011 Aug;67(8):825-31. doi: 10.1007/s00228-011-1002-y. Epub 2011 Feb 12.

PMID:
21318594
9.

Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age.

Vilo S, Rautiainen P, Kaisti K, Aantaa R, Scheinin M, Manner T, Olkkola KT.

Br J Anaesth. 2008 May;100(5):697-700. doi: 10.1093/bja/aen070. Epub 2008 Mar 31.

10.

Three-year clinical performance of cast gold vs ceramic partial crowns.

Federlin M, Wagner J, Männer T, Hiller KA, Schmalz G.

Clin Oral Investig. 2007 Dec;11(4):345-52. Epub 2007 Nov 1.

PMID:
17973129
11.

Periodontal healing after non-surgical therapy with a new ultrasonic device: a randomized controlled clinical trial.

Christgau M, Männer T, Beuer S, Hiller KA, Schmalz G.

J Clin Periodontol. 2007 Feb;34(2):137-47.

PMID:
17309588
12.

Management of the paediatric patient.

Aantaa R, Manner T.

Curr Opin Anaesthesiol. 1999 Dec;12(6):649-55.

PMID:
17016261
13.

Periodontal healing after non-surgical therapy with a modified sonic scaler: a controlled clinical trial.

Christgau M, Männer T, Beuer S, Hiller KA, Schmalz G.

J Clin Periodontol. 2006 Oct;33(10):749-58. Epub 2006 Aug 3.

PMID:
16889629
14.

Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children.

Antila H, Manner T, Kuurila K, Salanterä S, Kujala R, Aantaa R.

Paediatr Anaesth. 2006 May;16(5):548-53.

PMID:
16677265
15.

Two-year clinical performance of cast gold vs ceramic partial crowns.

Federlin M, Männer T, Hiller KA, Schmidt S, Schmalz G.

Clin Oral Investig. 2006 Jun;10(2):126-33. Epub 2006 Apr 14.

PMID:
16614863
16.

[Diagnosis and treatment of acute torsion and wandering spleen].

Hurme T, Reunanen M, Manner T, Jahnukainen T, Svedstrom E.

Duodecim. 2005;121(9):998-1000. Finnish. No abstract available.

PMID:
15991744
17.

Decreased binding of [11C]flumazenil in Angelman syndrome patients with GABA(A) receptor beta3 subunit deletions.

Holopainen IE, Metsähonkala EL, Kokkonen H, Parkkola RK, Manner TE, Någren K, Korpi ER.

Ann Neurol. 2001 Jan;49(1):110-3.

PMID:
11198279
18.

A survey of current usage of anticholinergic drugs in paediatric anaesthesia in Finland.

Rautakorpi P, Manner T, Kanto J.

Acta Anaesthesiol Scand. 1999 Nov;43(10):1057-9.

PMID:
10593471
19.

Barbiturate anesthesia and brain proton spectroscopy.

Lundbom NM, Manner T, Komu M, Peltola O, Leino KA, Kirvelä OA.

AJNR Am J Neuroradiol. 1999 Sep;20(8):1543-6.

20.

Metabolic and clinical responses to different types of premedication in children.

Rautakorpi P, Manner T, Kanto J, Lertola K.

Paediatr Anaesth. 1999;9(5):387-92.

PMID:
10447899
21.

A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.

Varho T, Komu M, Sonninen P, Holopainen I, Nyman S, Manner T, Sillanpää M, Aula P, Lundbom N.

Neurology. 1999 May 12;52(8):1668-72. Erratum in: Neurology 1999 Sep 22;53(5):1162.

PMID:
10331697
22.

Increased brain glucose utilization in Salla disease (free sialic acid storage disorder).

Suhonen-Polvi H, Varho T, Metsähonkala L, Haataja L, Ruotsalainen U, Haaparanta M, Bergman J, Solin O, Aärimaa T, Holopainen I, Vainionpää L, Manner T, Jääskeläinen S, Renlund M, Sillanpää M, Aula P.

J Nucl Med. 1999 Jan;40(1):12-8.

23.

Pharmacokinetics and oral bioavailability of glycopyrrolate in children.

Rautakorpi P, Manner T, Ali-Melkkilä T, Kaila T, Olkkola K, Kanto J.

Pharmacol Toxicol. 1998 Sep;83(3):132-4.

PMID:
9783332
24.

Proton spectroscopy in children with epilepsy and febrile convulsions.

Holopainen IE, Valtonen ME, Komu ME, Sonninen PH, Manner TE, Lundbom NM, Sillanpää ML.

Pediatr Neurol. 1998 Aug;19(2):93-9.

PMID:
9744626
25.

Differences in respiratory metabolism during treatment of hypoglycemia in infants of diabetic mothers and small-for-gestational-age infants.

Kinnala A, Manner T, Nuutila P, Korvenranta H, Kero P.

Am J Perinatol. 1998 Jun;15(6):363-7.

PMID:
9722056
26.

Lung compliance during laparoscopic surgery in paediatric patients.

Manner T, Aantaa R, Alanen M.

Paediatr Anaesth. 1998;8(1):25-9.

PMID:
9483594
27.

The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis.

Katz DP, Manner T, Furst P, Askanazi J.

Nutrition. 1996 May;12(5):334-9.

PMID:
8875517
28.

The antinociceptive effects of branched-chain amino acids: evidence for their ability to potentiate morphine analgesia.

Manner T, Katz DP, Askanazi J.

Pharmacol Biochem Behav. 1996 Feb;53(2):449-54.

PMID:
8808157
29.

Effect of substrate manipulation on reducing ischemia/reperfusion injury in isolated perfused rat hearts.

Wiese S, Askanazi J, Manner T, Katz DP, Buttrick P.

Clin Nutr. 1995 Apr;14(2):123-8.

PMID:
16843910
30.

Effects of valine, leucine, isoleucine, and a balanced amino acid solution on the seizure threshold to picrotoxin in rats.

Skeie B, Petersen AJ, Manner T, Askanazi J, Steen PA.

Pharmacol Biochem Behav. 1994 May;48(1):101-3.

PMID:
8029279
31.

Impact of specific substrate supply on efficiency of cardiac function: an update.

Wiese S, Katz DP, Manner T, Hollinger I, Askanazi J.

Nutrition. 1993 Nov-Dec;9(6):495-506. Review.

PMID:
8111139
32.

Fish oils and the lung.

Manner T, Katz DP, Skeie B, Newsholme E, Kirvelä O, Askanazi J.

Clin Nutr. 1993 Jun;12(3):131-46. No abstract available.

PMID:
16843303
33.

Branched-chain amino acids increase the seizure threshold to picrotoxin in rats.

Skeie B, Petersen AJ, Manner T, Askanazi J, Jellum E, Steen PA.

Pharmacol Biochem Behav. 1992 Nov;43(3):669-71.

PMID:
1333082
34.

Branched-chain amino acids and respiration.

Manner T, Wiese S, Katz DP, Skeie B, Askanazi J.

Nutrition. 1992 Sep-Oct;8(5):311-5. Review.

PMID:
1421777
35.

Long-term use of gamma-linolenic acid-enriched fat emulsion (PFE 4501): case report.

Söreide E, Skeie B, Katz DP, Manner T, Askanazi J.

Nutrition. 1992 May-Jun;8(3):182-5.

PMID:
1326350
36.

Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects.

Söreide E, Skeie B, Kirvelä O, Lynn R, Ginsberg N, Manner T, Katz DP, Askanazi J.

Kidney Int. 1991 Sep;40(3):539-43.

37.

Hormonal, haemodynamic, and subjective effects of intravenously infused indomethacin: no change in the physiological response to hypertonic saline challenge.

Manner T, Kanto J, Ruskoaho H, Karhuvaara S, Viinamäki O, Välimäki M, Scheinin M.

Pharmacol Toxicol. 1989 Sep;65(3):231-5.

PMID:
2530507
38.

Meptazinol and pentazocine: plasma catecholamines and other effects in healthy volunteers.

Manner T, Kanto J, Scheinin H, Scheinin M.

Br J Clin Pharmacol. 1987 Dec;24(6):689-97.

39.

Meptazinol and pentazocine: effects on prolactin, growth hormone and vasopressin levels in plasma.

Manner T, Kanto J, Scheinin H, Viinamäki O, Scheinin M.

Pharmacol Toxicol. 1987 Nov;61(5):301-4.

PMID:
3438224
40.
41.
42.

Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers.

Manner T, Kanto J, Salonen M.

Eur J Clin Pharmacol. 1987;31(6):673-6.

PMID:
3556374

Supplemental Content

Loading ...
Support Center